Search
forResearch 10 of 1000+
- Alopecia areata as another immune‐mediated disease developed in patients treated with tumour necrosis factor‐α blocker agents
- Psoriatic Alopecia/Alopecia Areata‐Like Reactions Secondary to Anti‐Tumour Necrosis Factor‐Alpha Therapy
- Tumor Promotion in Skin: Are Active Oxygen Species Involved?
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- [Hirsutism and hypertrichosis in adults: investigations and treatment].
- Montagna Symposium 2014—Skin Aging: Molecular Mechanisms and Tissue Consequences
- Alterazioni dei capelli da farmaci
- A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab
- Cancer Treatments and Alopecia: A Systematic Review
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
Learn 1 of 14
All learn results →Community
— no results
Try a deeper search in community →